Predictboard ·
🎯 Other
Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2027

Live
Resolves Jan 1, 2027Kalshi
Volume-weighted avg
3%
No
97%
No (97%)Yes (3%)
Check on Kalshi →
Probability History
Loading...
Market snapshot
Status
Open
Category
Other
Vol 24h
$5k
Liquidity
$13k

Market intelligence

Kalshi currently prices this at 3%. Kalshi has moved down 1pp over the past 7 days.

About this market

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes.

All outcomes · Will the FDA approve retatrutide?

Will the FDA approve retatrutide? — Before Jan 1, 2029
92%
Will the FDA approve retatrutide? — Before Jul 1, 2028
88%
Will the FDA approve retatrutide? — Before Jan 1, 2028
84%
Will the FDA approve retatrutide? — Before Jul 1, 2027
24%
Trade this marketLive prices
Avg probability
3%
probability of YES
Kalshi
3%Check
TGWA
Create Widget
Resolution
Jan 1, 2027
Market is open
Market stats
24h volume$5k
Liquidity$13k
CategoryOther
StatusOpen